benzoic acid maleate (ZCR-2060) was investigated on allergic cutaneous reactions and nasal vascular permeability in mice and rats. ZCR-2060 markedly inhibited immediate allergic cutaneous reactions, including passive cutaneous anaphylaxis (PCA) in rats and mice; histamine-, compound 48/80 and calcium ionophore A 23187-induced cutaneous reactions in rats; and biphasic skin reactions mediated by monoclonal IgE anti body and epicutaneous challenge with antigen in mice, but did not affect 5-hydroxytryptamine-induced cutaneous reaction in rats. The antigen-induced nasal vascular permeability increase in actively and passive ly sensitized rats and histamine-induced nasal vascular permeability increase in rats (allergic rhinitis model) were clearly inhibited in a dose-dependent fashion by ZCR-2060. Moreover, ZCR-2060 significantly inhib ited antigen-induced anaphylactic histamine release from rat peritoneal mast cells and carrageenin-induced paw edema in rats. These results suggest that ZCR-2060 has antiallergic effects on allergic cutaneous reac tions and experimental rhinitis, probably due to histamine H,-receptor blockage and the inhibition of histamine release.
2-[2-[4-(Diphenylmethyl)-1-piperadinyl]ethoxy]
benzo ic acid maleate (ZCR-2060) is a newly synthesized anti allergic agent. In our previous report (1), we showed that this compound antagonized the specific binding of 3H mepyramine to the membranes of guinea pig lung and brain and histamine-induced contraction of isolated guinea pig ileum and trachea, without affecting ileal con tractions induced by carbachol, 5-hydroxytryptamine (5 HT) and barium chloride. In addition, the histamine-in duced cutaneous reaction in rats was markedly inhibited by orally administered ZCR-2060. However, ZCR-2060, even at high doses, did not affect thiopental-induced sleep and spontaneous ambulatory activity in mice. These results suggest that ZCR-2060 selectively binds to the histamine H1-receptor, without affecting the CNS. In general, immediate hypersensitivity, which involves urticaria, allergic rhinitis and asthma, is mediated by vari ous chemical mediators released from mast cells or basophils (2) . It is well known that various anaphylactic chemical mediators are divided into preformed media tors, which include histamine and 5-HT, and newly syn thesized mediators, which include leukotrienes and PAF (3) . Various organs show distinct forms of immediate hypersensitivity involving different mediators and target cell types (4) . Consequently, antihistamines have been use ful in the management of allergic disorders caused by histamine (5) . Recently developed histamine H1-receptor antagonists such as terfenadine, cetirizine and astemizole have been shown to give better clinical results without the CNS side effects seen with classical antihistamines (6) . Furthermore, recent findings suggest that the newer non sedating antihistamines not only block the histamine H1 receptor but also inhibit chemical mediator release, inflam matory cell activation and infiltration (7) .
In the present study, the antiallergic effects of ZCR 2060 on experimental allergic cutaneous reaction and rhi nitis in mice and rats were investigated. The antiinflamma tory effect of the compound on carrageenin-induced paw edema in rats was also investigated.
MATERIALS AND METHODS

Animals
The following animals were used: female and male SD rats (weighing 120-270 g; Charles River Japan, Atsugi), male Wistar rats (weighing 150-200g; Japan SLC, Hamamatsu), male and female BALB/c mice (5 weeks of age, Charles River Japan or 10 weeks of age, Japan SLC).
Drugs
ZCR-2060, ketotifen fumarate (ketotifen) and cetiri zine dihydrochloride (cetirizine) were synthesized, and terfenadine was extracted from Triludane® (Shionogi, Osaka) in the Central Research Laboratory, Zeria Phar maceutical Co., Ltd. (Saitama). Prednisolone (acetate, aqueous suspension; Takeda, Osaka) and indomethacin (Sigma, St. Louis, MO, USA) were purchased commer cially.
For the in vivo studies, these drugs were suspended in 0.5% methyl cellulose saline solution. For the in vitro study, these drugs were dissolved in dimethylsulfoxide and diluted in phosphate-buffered saline (pH 7.4).
Antigens
Ascaris extract coupled with the 2,4-dinitrophenyl group (DNP-As) was prepared by the method of Tada and Okumura (8) . Bovine serum albumin (BSA, Sigma) was coupled with the DNP group according to the method of Lee and Sehon (9) . Dinitrofluorobenzen (DNFB; Nacalai Tesque, Kyoto) and ovalbumin (OA, Sigma) were also used.
Antisera and monoclonal antibody Rat anti-DNP and anti-OA IgE serum were prepared ac cording to the method of Tada and Okumura (8) . Briefly, female SD rats were immunized s.c. with 1 mg protein of DNP-As or OA with killed organisms (2 x 1010) of Bordetella pertussis (Wako, Osaka) by injection into the four food pads and then boosted by injecting i.m. 0.5 mg protein of DNP-As or OA alone 5 days later. They were then bled 3 days after the booster injection. The anti-DNP and anti-OA IgE antibody titers of each antiserum were 1 : 128-256 as estimated by 48-hr homologous PCA in rats. Monoclonal anti-DNP IgE antibody prepared in as cites fluid of BALB/c x C57BL/6 F1 mice was purchased from Serotec, Ltd. (Bicester, UK). The 48-hr PCA in the mouse ear titer of the antibody was 1 : 512-1024.
Forty-eight-hour homologous PCA in rats Male SD rats were injected intradermally with 0.1 ml of homologous anti-DNP IgE serum at 1/60 dilution into the shaved back. After 48 hr, PCA was elicited by an i.v. injection of 2.5 mg of DNP-BSA dissolved in 0.5% Evans blue saline solution in a volume of 1 ml. The animals were sacrificed 30 min after antigen challenge, and the skin sam ples were removed for the colorimetric measurement of the bluing spot. The amount of the dye extravasated due to PCA was measured by the method of Katayama et al. (10) . ZCR-2060 was administered orally 1 hr or at varying times before the antigen challenge. The other drugs were administered orally 1 hr before the antigen challenge.
Mediator or mediator releaser-induced cutaneous reac tions in rats This experiment was carried out according to the previ ously described method (11, 12) . Briefly, male Wistar rats were injected intradermally into the shaved back with 0.1 ml of histamine (dihydrochloride, 20 ug/ml; Nacalai Tesque), 5-HT (creatinine sulfate, 0.5 pg/ml; Sigma), compound 48/80 (0.5 ug/ml, Sigma) or calcium iono phore A23187 (A23187, 50 ug/ml; Sigma). Immediately after the injection, the animals received an intravenous in jection of 1 ml of 0.5010 Evans blue saline solution. Thirty minutes later, they were sacrificed and the reaction sites were excised for colorimetrical measurement of extrava sated dye. ZCR-2060 was administered orally 1 hr before the injection of each inducer.
IgE antibody-mediated mouse ear PCA PCA was elicited in the ear of male BALB/c mice as previously reported (13, 14) . Briefly, monoclonal anti DNP IgE antibody at 1/20 dilution was injected in a volume of 10 ul into each side of the ears under ether anesthesia. After 2 hr, mice were challenged with an in travenous injection of 0.25 ml of 0.5% Evans blue saline solution containing 0.25 mg of DNP-BSA. Thirty minutes later, the mice were sacrificed, and their ears were removed for determination of extravasated dye. Each drug was administered orally 1 hr before the antigen challenge.
IgE antibody-mediated biphasic skin reactions in mice This experiment was carried out according to the method reported previously (15) . Briefly, female BALB/c mice were passively sensitized by an i.v.-injection of monoclonal anti-DNP IgE antibody (1 ml/body). After 24 hr, biphasic skin reactions were induced by spreading the ears with 25 pl of DNFB at a concentration of 0.5% in acetone-olive oil (3 : 1). The ear thickness was measured with an engineer's micrometer (Ozaki, Tokyo) at 0, 1 and 24 hr after the challenge. Each drug was given intra peritoneally 1 hr before the antigen challenge.
Nasal vascular permeability induced by antigen and hista mine
These experiments were performed according to the method of Kojima et al. (16) using actively sensitized, passively sensitized and non-sensitized male SD rats. For active sensitization, rats were immunized with OA and killed Bordetella pertussis as previously described. The animals were operated on 13 or 14 days after the first im munization. Passive sensitization was carried out by an in jection of 5 ml/kg of homologous anti-OA IgE serum at 1 /4 dilution intravenously. After 48 hr, they were operat ed on. Non-sensitized rats were used to determine hista mine induced nasal vascular permeability. The sensitized and non-sensitized rats were anesthe tized by an i.p.-injection of pentobarbital sodium (30-40 mg/kg; Dinabot, Osaka). The trachea was cannu lated with a polyethylene tubing (PE-260; Clay Adams, Parsippany, NJ, USA) for spontaneous respiration. The nasal cannula was inserted through the cephalic end of the trachea into the nasal cavity. The nasopalatine was blocked with glycerinated cotton. Physiological saline, an tigen or histamine solution, which had been warmed at 371C, was perfused from the cannula through the nasal cavity at a rate of 0.25 ml/min with a peristaltic pump (Atto, Tokyo), and the perfusate was collected. Follow ing the operation, saline was perfusated for 10 min before (Period; P-0) and after (P-1) an i.v.-injection of 4010 Pon tamine sky blue (5 ml/kg, Sigma). Next, OA (1 mg/ml) or histamine (40 pg/ml) was perfused for 10 min at P-2. Fur thermore, saline alone was perfused, and the perfusate collected 4 times for 10 min at P-3 6. Each pooled perfu sate was centrifuged at 3,000 rpm for 10 min. The amount of dye in the soup was estimated colorimetrically at 620 nm. Each drug was administered orally 1 hr before the an tigen or histamine perfusion.
Antigen-induced histamine release from rat peritoneal mast cells
This experiment was performed according to the method reported previously (17) . Briefly, male SD rats received an i.p. injection of 1 ml of homologous anti DNP IgE serum. After 48 hr, they were bled and injected intraperitoneally with 10 ml/animal of Tyrode's solution (pH 7.4) containing 0.3% BSA and 5 units/ml heparin (Green Cross, Osaka). After gentle massage of the abdo men for 2 to 3 min, peritoneal cells were obtained and washed 3 times with Tyrode's solution. After counting the number of mast cells in the cell suspension by staining with 0.05010 toluidine blue (Chroma, Kongen, FRG), they were resuspended in Tyrode's solution containing 0.1010 BSA and 10 mM HEPES buffer (Gibco, Gaithersburg, MD, USA), and adjusted to a concentration of 1 x 105 cells/ml. The cell suspension was prewarmed for 5 min at 37'C, challenged with DNP-BSA at a final concentration of 10 pg/ml in the presence of 10 pg/ml phosphatidyl ser ine (Tokyo Kasei, Tokyo), and further incubated for 10 min. Histamine concentration in the supernatant was de termined by the method of Shore et al. (18) . The percent age of released histamine was calculated from the total cellular content of histamine in each experiment.
Carrageenin-induced paw edema
This experiment was performed according to the method reported previously (19) . Briefly, male SD rats were injected intradermally with 0.1 ml of 1 % carrageen in (Iwai, Tokyo) into the planter region of the right paw.
Statistics
The results are expressed as a mean±S.E. Either Student's or Welch's t-test was used after the F-test be tween the control and other groups. P<0.05 was consi dered to be significantly different.
RESULTS
Effect on 48-hr homologous PCA in rats
The efficacy of ZCR-2060 was compared with those of ketotifen, terfenadine and cetirizine when administered orally 1 hr before the antigen challenge. As shown in Table 1 , 48-hr homologous PCA was inhibited in a dose dependent fashion by both ZCR-2060 and ketotifen at doses of 0.1-1.0 mg/kg. Terfenadine and cetirizine inhib ited this PCA in a dose-dependent fashion at doses of 0. 3 10 mg/kg. The ID50 values of ZCR-2060, ketotifen, ter fenadine and cetirizine were 0.3, 0.3, 2.7 and 0.8 mg/kg, respectively. Note that ZCR-2060 was more potent than either terfenadine or cetirizine. As illustrated in Fig. 1 , a significant degree of inhibition by 1 mg/kg of ZCR-2060 was still observed 8 hr before the antigen challenge.
Effect on mediator or mediator releaser-induced cuta neous reactions in rats As shown in Fig. 2 , the histamine-induced cutaneous reaction was markedly inhibited by 1 mg/kg of ZCR-2060 administered orally 1 hr before histamine injection. In addition, ZCR-2060 inhibited significantly both the com pound 48/80 and A23187-induced cutaneous reactions. In contrast, the 5-HT-induced cutaneous reaction was not inhibited by ZCR-2060 at the same dose.
Effect of IgE antibody-mediated mouse ear PCA As shown in Table 2 , ZCR-2060 at doses of 0.3 -10 mg/kg inhibited IgE antibody-mediated mouse ear PCA in a dose-dependent fashion. Ketotifen (10 mg/kg) and cetirizine (30 mg/kg) significantly inhibited the mouse ear PCA. Terfenadine (10 and 30 mg/kg) caused slight inhibi tion of mouse ear PCA. Note that the efficacy of ZCR 2060 was greater than those of the other tested drugs. Monoclonal IgE antibody-mediated contact hypersen sitivity produced biphasic skin reactions with two peak responses, one at 1 (immediate phase) and one at 24 hr (late phase) after the antigen challenge. As shown in Fig. 3 , ZCR-2060 (10 and 30 mg/kg), when administered intraperitoneally 1 hr before the antigen challenge, sig nificantly inhibited both immediate and late phase skin reactions. Prednisolone (10 mg/kg), when administered intraperitoneally 2 hr before the antigen challenge, also inhibited both reactions.
Effect on antigen-induced nasal vascular permeability in sensitized rats
Antigen-induced nasal vascular permeabilities in active ly and passively sensitized rats were increased by extend ing the perfusion time after the antigen challenge, and both reached the maximum at P-5 (Figs. 4 and 5) . These extravasations were clearly inhibited by ZCR-2060 between P2-6. The amounts of dye leakage between P2 6 in these models are indicated in Tables 3 and 4 . ZCR-2060 (0.1 1.0 mg/kg) decreased the amount of dye leakage induced by antigen in actively and passively sensi tized rats in a dose-dependent fashion. Ketotifen (0.3 or 1.0 mg/kg), terfenadine (3 mg/kg) and cetirizine (1 mg/kg) also inhibited dye leakage. Note that the inhibi tory effect of ZCR-2060 and other drugs were stronger in actively sensitized rats than in passively sensitized rats. 
Effect on histamine-induced nasal vascular permeability
As shown in Fig. 6 , the extravasated dye in the nasal cavity increased by extending the perfusion time after the histamine treatment, and this reached the maximum at P 5. ZCR-2060 (0.3 3 mg/kg) significantly inhibited the histamine-induced increase in dye leakage in nasal cavities at each point. As summarized in Table 5 , doses of 0.3 3 mg/kg of either ZCR-2060 or ketotifen inhibited the dye leakage in a dose-dependent fashion. Terfenadine (1, 3 mg/kg) and cetirizine (0.3, 1 mg/kg) also clearly inhibited this model. Note that the efficacy of ZCR-2060 was higher than those of terfenadine and cetirizine, and it was almost the same as that of ketotifen.
Effect on antigen-induced histamine release from rat peritoneal mast cells
As illustrated in Fig. 7 , anaphylactic histamine release was clearly inhibited in a dose-dependent fashion by both ZCR-2060 and cetirizine at concentrations of 10-6-10-4 M. Ketotifen markedly inhibited the anaphylactic hista mine release. In contrast, terfenadine at 10-5 M did not affect the anaphylactic histamine release (data not shown).
Effect on carrageenin-induced paw edema in rats
As shown in Table 6 , the paw edema caused by car rageenin was significantly inhibited by 10 mg/kg of ZCR 2060 1-4 hr after the carrageenin injection. Note that the maximum inhibitory effect of ZCR-2060 was observed during the early phase (1 hr). Ketotifen (10 mg/kg), ter fenadine (100 mg/kg) and cetirizine (30 mg/kg) did not affect the paw edema. In contrast, indomethacin in a dose of 3 mg/kg markedly inhibited the response 1 -4 hr after the carrageenin injection. 
DISCUSSION
Immediate hypersensitivity reactions of the skin, nose and airway of experimental animals sensitized with IgE antibody have been used as models for allergic skin reac tions such as urticaria or atopic eczema, allergic rhinitis and bronchial asthma in humans (14) . PCA is one of the most important in vivo models of immediate hypersen sitivity in allergic cutaneous reactions. Rat or guinea pig dorsal skin and mouse ear are useful sites for studying PCA (11, 13) . Experimental allergic rhinitis has usually been induced by intranasal application of antigen in sensi tized animals, resulting in an increased nasal vascular permeability and intranasal resistance (16, 20, 21) . In spite of the increasing evidence of the role of several other mediators (22, 23) , histamine is still regarded as the prin cipal mediator of antigen-induced allergic skin reactions and rhinitis. In addition, intradermal and intranasal appli cation of chemical mediators and chemical mediator re leasers increase vascular permeability in a manner similar to that of allergic models (12, 14) .
In the present study, the antiallergic effects of ZCR 2060 in experimental allergic skin reactions and rhinitis in rats and mice were investigated, and they were compared with those of ketotifen, terfenadine and cetirizine. ZCR 2060 clearly inhibited immediate allergic skin reaction and rhinitis models in mice and rats. The efficacy of ZCR 2060 was greater than those of terfenadine and cetirizine, and it was almost the same as that of ketotifen. Note that the inhibitory activity of ZCR-2060 and other tested drugs on allergic rhinitis models was stronger in actively sensitized animals than in passively sensitized animals. Kojima et al. (16) reported that tranilast also had a strong er effect on actively sensitized animals. In contrast, the classical histamine H,-receptor antagonist diphenhydra mine did not affect the allergic rhinitis model in passively sensitized animals. Although these findings are not com pletely understood, it is certain that ZCR-2060 is effective against immediate allergic skin reactions and rhinitis. Furthermore, ZCR-2060 inhibited the histamine-induced cutaneous reaction and nasal vascular permeability, com pound 48/80 and A23187-induced cutaneous reactions, but did not affect the 5-HT-induced cutaneous reaction in rats. In addition, ZCR-2060 inhibited the antigen-in duced histamine release from rat peritoneal mast cells. It is well known that rat mast cell contains histamine, 5-HT and other chemical mediators and that these mediators are released by immunological and non-immunological stimuli (24) . It has been reported that compound 48/80 in duces the chemical mediators released by interaction with a specific receptor on the mast cells (25) , and A23187 stimulates the release process by facilitating the influx of Ca 21 into the mast cells (26) . These results indicate that the antiallergic effect of ZCR-2060 on immediate hyper sensitivity is due not only to blockage of the histamine H,-receptor, but also to inhibition of chemical mediator release, and that this antiallergic effect is long lasting.
Recently, much attention has been paid to late phase reactions in the skin, nose and airway which are character ized by an infiltration of inflammatory leukocytes includ ing eosinophils, basophils, neutrophils and mononuclear cells (7) . Late phase reactions have been observed several hours after immediate hypersensitivity elicited by antigen challenge. Infiltration of activated inflammatory cells leads to the generation and release of multiple mediators that produce various allergic disorders in various target organs (7, 27) . These biphasic responses are believed to reflect the clinical symptoms of chronic allergic disorders. Ray et al. (28) demonstrated that monoclonal anti-DNP IgE antibody mediated the biphasic responses of immedi ate and late phase reactions in mouse ears. Katayama et al. (29) reported that biphasic responses were hapten specific and mast cell-dependent because WBB6F,-W/W`' mice, which are mast cell deficient mice, showed no biphasic responses. Sakurai et al. (15) reported that prednisolone and dexamethasone inhibited both biphasic responses and that the classical histamine H,-receptor an tagonists, such as diphenhydramine and homochlorcycli zine, inhibited the immediate phase response, but not the late phase response. In the present study, ZCR-2060 and prednisolone significantly inhibited both biphasic skin reactions in mice. It has been reported that cetirizine in hibited the allergen-induced migration of inflammatory cells in late phase reactions of skin and lung (7, 30, 31) . It has been reported that histamine release could be iden tified in the biphasic responses of both nose and skin (32, 33) . We observed that ZCR-2060 inhibited the antigen-in duced migration of inflammatory cells in bronchoalveolar lavage fluids of actively sensitized guinea pigs (34) . Moreover, ZCR-2060 inhibited carrageenin-induced rat paw edema, which is a non-allergic inflammation, and was found to be more potent than other antihistamines. Therefore, these findings clearly show that ZCR-2060 inhibits immediate and late phase allergic responses, caused by histamine H,-receptor blockade, inhibition of chemical mediators release and antiinflammatory action. It also suggests that ZCR-2060 might be useful in the treat ment of allergic skin reactions and rhinitis in humans.
